InspireMD entered a new $75M at-the-market equity offering agreement with BTIG and terminated its prior $75M ATM agreement with Piper Sandler, having sold 1,361,519 shares under the prior program.
Key takeaways
Entered Equity Distribution Agreement with BTIG for up to $75,000,000 of common stock in ATM offering.
BTIG entitled to up to 3.0% commission on gross proceeds.
Terminated prior Piper EDA effective April 3, 2026 with no penalties.
Sold 1,361,519 shares under terminated Piper Sandler ATM program.
Net proceeds for operations, R&D, sales/marketing, working capital.
Shares issued under S-3 Registration Statement No. 333-286309.